SGAM
ARIA

Steinberg Global Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Steinberg Global Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-47,100
Closed -$586K – 238
2016
Q4 		$586K Hold
47,100
– – 0.1% 148
2016
Q3 		$645K Hold
47,100
– – 0.11% 137
2016
Q2 		$348K Hold
47,100
– – 0.06% 170
2016
Q1 		$301K Buy
47,100
+5,300
+13% +$29.7K 0.06% 177
2015
Q4 		$261K Sell
41,800
-86,381
-67% -$567K 0.05% 192
2015
Q3 		$748K Buy
128,181
+75,906
+145% +$585K 0.15% 109
2015
Q2 		$432K Buy
+52,275
New +$462K 0.08% 160

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Steinberg Global Asset Management's ARIA Position: Q1 2017 in Review

Steinberg Global Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 47,100 shares — an estimated $586K sold.

Steinberg Global Asset Management first reported a position in ARIA in Q2 2015 and held it in 7 quarters. The position peaked at $748K in Q3 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Steinberg Global Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Steinberg Global Asset Management sold 47,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $586K.
  • Steinberg Global Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2015 and held it in 7 quarters.
  • Steinberg Global Asset Management's Ariad Pharmaceuticals Inc position peaked at $748K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Steinberg Global Asset Management's 13F filing for Q1 2017, filed 11 May 2017.